In women and nonbinary people, monkeypox cases might have been missed. Among cisgender women and nonbinary individuals who were assigned female at birth, only 61% of monkeypox cases could be connected to sexual contact. (The New York Times)

COVID-19 has been linked to detectable brain changes, according to a recent report. The scientists found that most of the people who had recovered from COVID-19 had changes in the circulation of tiny blood vessels in the frontal lobe and brain stem areas, which are involved in higher order cognitive skills such as language expression and voluntary movements. (TIME)

GSK pulled blenrep, a blood cancer drug, after a clinical trial failure. Still, GSK said it is not giving up on blenrep. The company is pursuing a number of ongoing trials of the drug, including two in which it is administered in combination with other drugs. (Barron’s)

A new study suggested that HDL or ‘good’ cholesterol is less beneficial than previously thought, especially for Black adults. Additionally, higher levels of HDL cholesterol were not found to reduce the risk of cardiovascular disease for either group. (CNN)

The shortage of Ozempic has caused a problem in Connecticut as the medication is sought by dieters seeking weight-loss benefits touted in a social media trend. The Ozempic shortage has lasted one to two months so far, said Dr. Devika Umashanker of Hartford HealthCare, while the Wegovy shortage has gone on much longer. (Hartford Courant)